Insulin for the treatment of women with gestational diabetes

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 11, 2017, Pages

  Brown, Julie ^a   Grzeskowiak, Luke ^b   Williamson, Kathryn ^c   Downie, Michelle R ^d   Crowther, Caroline A ^a,e  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d SOUTHLAND HOSPITAL   (New Zealand)

^e UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ASTRAGALUS EXTRACT; BIPHASIC INSULIN; CHLORPROPAMIDE; GLIBENCLAMIDE; HEMOGLOBIN A1C; HUMALIN N; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; LONG ACTING INSULIN; METFORMIN; NEUTRAL INSULIN; NOVOPEN 3; ORAL ANTIDIABETIC AGENT; RECOMBINANT HUMAN INSULIN; SHORT ACTING INSULIN; TOLBUTAMIDE; ANTIDIABETIC AGENT;

APGAR SCORE; BEDTIME DOSAGE; BEHAVIOR CHANGE; BLOOD GLUCOSE MONITORING; BODY HEIGHT; BODY MASS; BODY WEIGHT; BREAST FEEDING; CARBOHYDRATE INTAKE; CESAREAN SECTION; CLINICAL OUTCOME; CONGENITAL DISORDER; CONTINUOUS INFUSION; DEVELOPMENTAL DELAY; DIET; DIET RESTRICTION; DOSAGE SCHEDULE COMPARISON; DRUG COST; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG WITHDRAWAL; ECLAMPSIA; ETHNICITY; EVENING DOSAGE; EXERCISE; FAMILY HISTORY; FAT MASS; FETUS MORTALITY; FRACTURE; FUNDING; GASTROINTESTINAL SYMPTOM; GESTATIONAL WEIGHT GAIN; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEAD CIRCUMFERENCE; HEALTH CARE UTILIZATION; HIGH INCOME COUNTRY; HUMAN; HYPERBILIRUBINEMIA; HYPERGLYCEMIA; HYPOCALCEMIA; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LABOR INDUCTION; LARGE FOR GESTATIONAL AGE; LENGTH OF STAY; LIFESTYLE MODIFICATION; LOW INCOME COUNTRY; MACROSOMIA; MATERNAL AGE; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MIDDLE INCOME COUNTRY; MORNING DOSAGE; MULTIPLE PREGNANCY; NEONATAL INTENSIVE CARE UNIT; NEWBORN DEATH; NEWBORN JAUNDICE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PARITY; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; PERINEUM INJURY; PHYSICAL INACTIVITY; POLYCYTHEMIA; POSTNATAL DEPRESSION; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; PUERPERAL INFECTION; QUALITY OF LIFE; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SHOULDER DYSTOCIA; SINGLE DRUG DOSE; SKINFOLD THICKNESS; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; STILLBIRTH; SYSTEMATIC REVIEW; VISUAL IMPAIRMENT; WEIGHT GAIN; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; META ANALYSIS; NEWBORN; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA;

ADIPOSITY; BODY WEIGHT; CESAREAN SECTION; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; INSULIN; LABOR, INDUCED; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85032732031     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD012037.pub2     Document Type: Review

References (222)

1. Anjalakshi C, Balaji B, Balaji MS, Seshiah V. A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women. Diabetes Research and Clinical Practice 2007;76(3):474-5. 6908525
2. Ardilouze JL, Menard J, Hivert MF, Perron P, Houde G, Moutquiin JM, et al. Gestational diabetes mellitus: a randomized study comparing insulin therapy to a combination of half-maximal dosages of metformin and glyburide. Diabetes 2014;63:A630. 6908527
3. Ardilouze JL, Menard J, Perron P, Houde G, Moutquin JM, Hivert MF, et al. Gestational diabetes mellitus: the first prospective randomised study of metformine-glyburide vs insulin. Diabetologia 2014;57(Suppl 1):S449-S450. 6908528
4. NCT01215331. Gestational diabetes mellitus: insulin or oral hypoglycemic agents?. clinicaltrials.gov/show/NCT01215331 Date first received: 5 October 2010. [NCT01215331]6908529
5. Ashoush S, El-Said M, Fathi H, Abdelnaby M. Identification of metformin poor responders, requiring supplemental insulin, during randomization of metformin versus insulin for the control of gestational diabetes mellitus. Journal of Obstetrics and Gynaecology Research 2016;42(6):640-7. 6908531
6. Balaji V, Seshiah V, Balaji MS. Insulin aspart - Safe during pregnancy. Diabetes 2005;54:A133. 6908533
7. Balaji V, Balaji MS, Alexander C, Ashalata S, Suganthi RS, Suresh S, et al. Premixed insulin aspart 30 (BIAsp 30) vs. premixed human insulin 30 (BHI 30) in gestational diabetes mellitus--a pilot study. Journal of Association of Physicians of India 2010;58(2):95-7. 6908535
8. Balaji V, Balji MS, Alexander C, Srinivasan A, Suganthi SR, Thiyagarajah A, et al. Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study. Gynecological Endocrinology 2012;28(7):529-32. 6908536
9. CTRI/2011/091/000093. Insulin in gestational diabetes mellitus - a randomised controlled study. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=2613 Date first received: 10 February 2011. 6908537
10. Seshiah V, Balaji V, Balaji MS, Alexander C, Srinivasan A, Suganthi S, et al. BIAsp 30 was well tolerated and non-inferior to BHI 30 in the management of GDM: Findings from a randomized trial. Diabetes 2011;60:A637. 6908538
11. Behrashi M, Samimi M, Ghasemi T, Saberi F, Atoof F. Comparison of glibenclamide and insulin on neonatal outcomes in pregnant women with gestational diabetes. International Journal of Preventive Medicine 2016;7:88. 6908540
12. Bertini AM, Silva JC, Taborda W, Becker F, Bebber FR, Viesi JM, et al. Perinatal outcomes and the use of oral hypoglycemic agents. Journal of Perinatal Medicine 2005;33(6):519-23. 6908542
13. Silva JC, Taborda W, Becker F, Aquim G, Viese J, Bertini AM. Preliminary results of the use of oral hypoglycemic drugs on gestational diabetes mellitus [Resultados preliminares do uso de anti-hiperglicemiantes orais no diabete melito gestacional]. Revista Brasileira de Ginecologia y Obstetricia 2005;27(8):461-6. 6908543
14. Beyuo T. A study of metformin versus insulin in the management of gestational diabetes mellitus and type 2 pre-gestational diabetes mellitus at Korle Bu Teaching Hospital. Accra: University of Ghana Medical School, 2013. 6908546
15. Beyuo T, Obed SA, Adjepong-Yamoah KK, Bugyei KA, Oppong AS, Marfoh K. Metformin versus insulin in the management of pre-gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS One 2015;10(5):e0125712. 6908545
16. Bung P, Bung C, Artal R, Khodiguian N, Fallenstein F, Spatling L. Therapeutic exercise for insulin-requiring gestational diabetics: effects on the fetus - results of a randomized prospective longitudinal study. Journal of Perinatal Medicine 1993;21:125-37. 6908548
17. Castorino K, Wollitzer AO, Petitt DJ, Zisser H, Jovanovic L. 50/50 insulin mix 3x per day simplifies insulin regimen in GDM. 71st Scientific Sessions of the American Diabetes Association; 2011, June 24-28; San Diego, California;. 2011:Abstract no: DIAEAZ 60. 6908550
18. Coustan DR, Lewis SB. Insulin therapy for gestational diabetes. Obstetrics & Gynecology 1978;51:306-10. 6908552
19. De Veciana M, Trail PA, Evans AT, Dulaney K. A comparison of oral acarbose and insulin in women with gestational diabetes. Obstetrics & Gynecology 2002;99(4 Suppl):5S. 6908554
20. Di Cianni G, Volpe L, Ghio A, Lencioni C, Cuccuru I, Benzi L, et al. Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin. Diabetes Care 2007;30(4):e11. 6908556
21. Hague WM, Davoren PM, Oliver J, Rowan J. Contraindications to use of metformin. Metformin may be useful in gestational diabetes. BMJ 2003;326:762. 6908558
22. Herrera K, Rosenn B, Foroutan J, Bimson B, Al Ibraheemi Z, Brustman L. A randomised controlled trial of insulin determir versus insulin NPH for the treatment of pregnant women with gestational diabetes and type 2 diabetes. American Journal of Obstetrics and Gynecology 2015;212(1 Suppl):S320. 6908560
23. Herrera K, Rosenn B, Foroutan J, Bimson B, Al-Ibraheemi Z, Scarpelli S, et al. Insulin detemir vs. NPH: association with maternal weight gain in pregnancy. Diabetes 2015;64:A675. 6908561
24. Herrera KM, Rosenn BM, Foroutan J, Bimson BE, Al Ibraheemi Z, Moshier EL, et al. Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes. American Journal of Obstetrics & Gynecology 2015;426:e1-e7. 6908562
25. NCT01837680. Insulin detemir versus insulin NPH: a randomized prospective study comparing glycemic control in pregnant women with diabetes. clinicaltrials.gov/show/NCT01837680 Date first received: 4 April 2013. 6908563
26. Hickman MA, McBride R, Boggess KA, Strauss R. Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology 2013;30:483-90. 6908565
27. NCT00835861. Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/show/NCT00835861 Date first received: 2 February 2009. 6908566
28. Hutchinson A, Haugabrook C, Long L, Mason L, Kipikasa J, Adair D. A comparison of glyburide/metformin and insulin for gestational diabetes. American Journal of Obstetrics and Gynecology 2008;199(6 Suppl 1):S200. 6908568
29. NCT00371306. Comparison of glucovance to insulin for diabetes during pregnancy. clinicaltrials.gov/show/NCT00371306 Date first received: 1 September 2006. 6908569
30. Ijas H, Vaarasmaki M, Morin-Papunen L, Keravuo R, Ebeling T, Saarela T, et al. Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG: an international journal of obstetrics and gynaecology 2011;118(7):880-5. 6908571
31. Ijas H, Vaarasmaki M, Saarela T, Keravuo R, Raudaskoski T. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months. BJOG: an international journal of obstetrics and gynaecology 2014;122(7):994-1000. 6908572
32. NCT01087866. Metformin versus insulin in the treatment of gestational diabetes. clinicaltrials.gov/show/NCT01087866 Date first received: 15 March 2010. 6908573
33. Ismail NAM, Nor NA, Sufian SS, Mustafa N, Jamil MA, Kamaruddin NA. Comparative study of two insulin regimes in pregnancy complicated by diabetes mellitus. Acta Obstetricia et Gynecologica Scandinavica 2007;86(4):407-8. 6908575
34. Jovanovic L, Ilic S, Petitt DJ, Hugo K, Cutierrez M, Bowsher RR, et al. Metabolic and immunological effects of insulin lispro in gestational diabetes. Diabetes Care 1999;22(9):1422-27. 6908577
35. Lain K, Garabedian M, Daftary A, Jeyabalan A. Maternal and neonatal metabolic biomarkers in gestational diabetes treated with glyburide compared to insulin. American Journal of Obstetrics and Gynecology 2008;199(6 Suppl 1):S199. 6908579
36. Lain K, Garabedian M, Daftary A, Jeyabalan A. Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared to insulin. American Journal of Obstetrics and Gynecology 2008;199(6 Suppl 1):S34. 6908580
37. Lain KY, Garabedian MJ, Daftary A, Jeyabalan A. Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared with insulin. American Journal of Obstetrics and Gynecology 2009;200(5):501.e1-501.e6. 6908581
38. Langer O, Conway D, Berkus M, Xenakis E-J. Oral hypoglycaemic agent is comparable to insulin in GDM management. American Journal of Obstetrics and Gynecology 1999;180(1 Pt 2):S6. 6908583
39. Langer O, Conway D, Berkus M, Xenakis EJ, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. New England Journal of Medicine 2000;343(16):1134-8. 6908584
40. Langer O, Yogev Y, Brustman L, Rosenn B. Is there a relationship between severity of gestational diabetes (gdm) and pregnancy outcome in insulin- and glyburide-treated patients. American Journal of Obstetrics and Gynecology 2003;189(6):S105. 6908585
41. Langer O, Yogev Y, Rosenn B, Brustman L. Glyburide therapy: the relationship between dosage and level of gestational diabetes (GDM) severity. American Journal of Obstetrics and Gynecology 2003;189(6):S105. 6908586
42. Langer O, Yogev Y, Xenakis EMJ, Rosenn B. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. American Journal of Obstetrics and Gynecology 2005;192(1):134-9. 6908587
43. Majeed T, Adnan R, Mubshar I, Saba K, Imam SF, Al-Fareed Zafar M, et al. To compare the efficacy of metformin with insulin in diabetes mellitus in terms of fetomaternal outcome. Professional Medical Journal 2015;22(10):1298-303. 6908589
44. Martinez Piccole S, Abdulhaj Martinez M, Andres Nunez P, Garcia Leon P, Lopez Sanchez EJ, Gonzalez Ramirez AR. A randomized study comparing metformin and insulin in the treatment of gestational diabetes mellitus. Interim results. Journal of Maternal-Fetal and Neonatal Medicine 2010;23(S1):381. 6908591
45. Mecacci F, Carignani L, Cioni R, Bartoli E, Parretti E, La Torre P, et al. Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women. European Journal of Obstetrics & Gynecology and Reproductive Biology 2003;111(1):19-24. 6908593
46. IRCT201104162699N5. Comparison of newborn outcomes in women with gestational diabetes treated with metformin or insulin. en.search.irct.ir/view/5752 Date first received: 13 May 2011. 6908595
47. Mesdaghi E, Samimi M, Homaei Z, Saberi F, Moosavi SGA, Yaribakht M. Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a randomised blinded trial. Diabetes Technology and Therapeutics 2013;15:A-11. 6908596
48. Mesdaghinia E, Samimi M, Saberi F, Moosavi SGA, Yaribakht M. Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a randomised blinded trial. International Journal of Preventive Medicine 2013;4(3):327-33. 6908597
49. IRCT2013071010876N2. Comparison of gliburide and insulin in women with gestational diabetes mellitus and associated perinatal outcome. http://en.search.irct.ir/view/14273 date received 22 June 2014. 6908599
50. Mirzamoradi M, Heidar Z, Faalpoor Z, Naeiji Z, Jamali R. Comparison of glyburide and insulin in women with gestational diabetes mellitus and associated perinatal outcome: a randomized clinical trial. Acta Medica Iranica 2015;53(2):97-103. 6908600
51. Mohamed MA, Abdelmonem AM, Abdellah MA, Elsayed AA. Oral hypoglycaemic as attractive alternative to insulin for the management of diabetes mellitus during pregnancy. Gynecology & Obstetrics 2014;4(1):1000193. 6908602
52. Moore L, Briery C, Martin R, Hood E, Bofill J, Morrison J. Metformin (M) vs. insulin (I) in A2 diabetes: a randomized clinical trial. American Journal of Obstetrics and Gynecology 2004;191(6 Suppl 1):S8. 6908604
53. Moore L, Clokey D, Robinson A. A randomized trial of metformin compared to glyburide in the treatment of gestational diabetes. American Journal of Obstetrics and Gynecology 2005;193(6 Suppl):S92. 6908605
54. Moore LE, Briery CM, Clockley D, Martin RW, Williford NJ, Bofill JA, et al. Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison. Journal of Reproductive Medicine 2007;52(11):1011-5. 6908606
55. Mukhopadhyay P, Sankar Bag T, Kyal A, Prasun Saha D, Khalid N. Oral hypoglycaemic glibenclamide: can it be a substitute to insulin in the management of gestational diabetes mellitus? A comparative study. Journal of the Southern Asian Federation of Obstetrics and Gynaecology 2012;4(1):28-31. 6908608
56. Nachum Z, Ben-Shlomo I, Weiner E, Shalev E. Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial. BMJ 1999;319:1223-7. 6908610
57. IRCT201105075591N2. Metformin compared with insulin in control of blood sugar in gestational diabetes mellitus. en.search.irct.ir/view/5930 Date first received: 31 May 2011. [IRCT201105075591N2]6908612
58. Niromenesh S, Alavi A, Sharbaf F, Amjadi N, Moosavi S, Akbari S. Metformin compared with insulin in the management of gestational diabetes mellitus: A randomised clinical trial. Diabetes Research and Clinical Practice 2012;98(3):422-9. 6908613
59. Notelovitz M. Sulphoylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal 1971;45(9):226-9. 6908615
60. O'Sullivan JB. Prospective study of gestational diabetes and its treatment. In: Sutherland HW, Stowers JM editor(s). Carbohydrate and Metabolism in Pregnancy and the Newborn. Edinburgh, New York and London: Churchill Livingstone, 1975. 6908618
61. O'Sullivan JB, Mahan CM. Insulin treatment and high risk groups. Diabetes Care 1980;3:482-5. 6908617
62. O'Sullivan JB. Prospective study of gestational diabetes and its treatment. In: Sutherland HW, Stowers JM editor(s). Carbohydrate and Metabolism in Pregnancy and the Newborn. Edinburgh, New York and London: Churchill Livingstone, 1975. 6908620
63. Ogunyemi D, Jesse M, Davidson M. Comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocrine Practice 2007;13(4):427-8. 6908622
64. Ogunyemi, D. Jesse, M. Ajaji, S. Sanchez, J. A comparison of glyburide and insulin in management of gestational diabetes mellitus. Obstetrics and Gynecology 2006;107(4 Suppl):35S-36S. 6908623
65. Pavithra I, Pillai SK, Vijayaraghavan J. A comparison of insulin and glibenclamide in the treatment of gestational diabetes mellitus. Indian Journal of Obstetrics and Gynecology Research 2016;2(4):270-5. 6908625
66. Persson B, Stangenberg M, Hansson U, Nordlander E. Gestational diabetes mellitus (GDM): comparative evaluation of two treatment regimens, diet vs insulin and diet. Diabetes 1985;34:101-5. 6908627
67. Jovanovic L, Howard C, Petitt D, Zisser H, Ospina P. Safety and efficacy of insulin aspart vs regular human insulin in basal/bolus therapy for patients with gestational diabetes. American Diabetes Association 65th Scientific Sessions; 2005, June 10-14; San Diego, California, USA. San Diego, California, 2005. 6908629
68. Jovanovic L, Howard C, Pettitt D, Zisser H, Ospina P. Insulin aspart vs regular human insulin in basal/bolus therapy for patients with gestational diabetes mellitus: safety and efficacy. Diabetologia 2005;48(Suppl 1):A317. 6908630
69. NCT00065130. Safety and efficacy of insulin aspart vs. regular human insulin in gestational diabetes. clinicaltrials.gov/show/NCT00065130 Date first received: 17 July 2003. 6908631
70. Petitt DJ, Ospina P, Howard C, Zisser H, Jovanovic L. Efficacy, safety and lack of immunogenicity of insulin aspart compared with regula human insulin for women with gestational diabetes mellitus. Diabetic Medicine 2007;24:1129-35. 6908632
71. Poyhonen-Alho M, Teramo K, Kaaja R. Treatment of gestational diabetes with short or long-acting insulin and neonatal outcome: a pilot study. Acta Obstetricia et Gynecologica Scandinavica 2002;81(3):258-9. 6908634
72. Prasad S, Prasad GM. Maternal and perinatal outcome in using insulin aspart versus regular insulin in gestational diabetes mellitus. Diabetes Care 2008;57(Suppl 1):A581. 6908636
73. Riaz A, Hussain R, Sultana N. Comparison of metformin and insulin for the management of gestational diabetes. Pakistan Journal of Medical and Health Sciences 2014;8(1):194-6. 6908638
74. ACTRN12605000311651. Metformin in gestational diabetes: the offspring follow-up. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=335 Date first received: 6 September 2005. 6908640
75. Barrett HL, Gatford KL, Houda CM, De Blasio MJ, McIntyre HD, Callaway LK, et al. Maternal and neonatal circulating markers of metabolic risk in the metformin in gestational diabetes (MiG) trial. Diabetes Care 2013;36:529-36. 6908641
76. Barrett HL, Nitert DM, Jones L, O'Rourke P, Lust K, Gatford KL, et al. Determinants of maternal triglycerides in women with gestational diabetes in the metformin in gestational diabetes (MiG) trial. Diabetes Care 2013;36:1941-6. 6908642
77. Battin M, Wouldes T, Buksh M, Rowan J. Neurodevelopmental outcome at 24 months in children following a randomized trial of metformin versus insulin treatment for gestational diabetes (miG trial). Journal of Paediatrics and Child Health 2013;49(Suppl 2):21. 6908643
78. Battin MR, Obolonkin V, Rush E, Hague W, Coat S, Rowan J. Blood pressure measurement at two years in offspring of women randomized to a trial of metformin for GDM: follow-up data from the MiG trial. BMC Pediatrics 2015;15:54. 6908644
79. Gatford KL, Houda CM, Lu ZX, Coat S, Baghurst PA, Ownes JA, et al. Vitamin B12 and homocysteine status during pregnancy in the metformin in gestational diabetes trial: responses to maternal metformin compared with insulin treatment. Diabetes, Obesity and Metabolism 2013;15:660-7. 6908645
80. Rowan JA, Gao W, Hague WM, McIntyre HD. Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial. Diabetes Care 2010;33(1):9-16. 6908646
81. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP, for the MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. New England Journal of Medicine 2008;358(19):2003-15. 6908647
82. Rowan JA, Rush EC, Obolonkin V, Battin M, Wouldes T, Hague WM. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care 2011;34(10):2279-84. 6908648
83. Rowan JA, on behalf of the MiG Investigators. A trial in progress: gestational diabetes. Diabetes Care 2007;30(Suppl 2):S214-S219. 6908649
84. Wouldes TA, Battin M, Coat S, Rush EC, Hague WM, Rowan JA. Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes. Archives of Disease in Childhood. Fetal and Neonatal Edition 2016;101(6):F488-93. 6908650
85. IRCT201306057841N4. Neonatal outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a randomized clinical trial. en.search.irct.ir/view/13839 Date first received: 8 June 2013. 6908652
86. Ruholamin S, Eshaghian S, Allame Z. Neonatal outcomes in women with gestational diabetes mellitus treated with metformin in compare with insulin: a randomized clinical trial. Journal of Research in Medical Sciences 2014;19:970-5. 6908653
87. Saleh HS, Abdelsalam WA, Mowafy HE, Abd ElHameid AA. Could metformin manage gestational diabetes mellitus instead of insulin?. International Journal of Reproductive Medicine 2016;2016:Article ID: 3480629. 6908655
88. Silva JC, Bertini AM, Taborda W, Becker F, Bebber FR, Aquim GM, et al. Glibenclamide in the treatment for gestational diabetes mellitus in a compared study to insulin. Arquivos Brasileiros de Endocrinologia e Metabologia 2007;51(4):541-6. 6908657
89. JPRN-UMIN000005393. Comparision metformin and insulin for treatment of diabetes gestational. upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006403 Date first received: 9 April 2011. 6908659
90. Spaulonci CP, Bernardes LS, Trindade TC, Zugaib M, Francisco RPV. Randomized trial of metformin versus insulin in the management of gestational diabetes. American Journal of Obstetrics and Gynecology 2013;209(1):34.e1-34.e7. 6908660
91. NCT02417090. Late metabolic effects of metformin therapy in gestational diabetes (DIARA2). clinicaltrials.gov/ct2/show/NCT02417090 Date first received: 10 April 2015. 6908662
92. Pellonpera O, Ronnemaa T, Ekblad U, Vahlberg T, Tertti K. The effects of metformin treatment of gestational diabetes on maternal weight and glucose tolerance post-partum- a prospective follow-up study. Acta Obstetricia et Gynecologica Scandinavica 2016;95(1):79-87. 6908663
93. Tertti K, Ekblad U, Koskinen P, Vahlberg T, Ronnemaa T. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes, Obesity & Metabolism 2013;15(3):246-51. 6908664
94. Tertti K, Eskola E, Ronnemaa T, Haataja L. Neurodevelopment of two-year old children exposed to metformin and insulin in gestational diabetes mellitus. Journal of Developmental and Behavioral Pediatrics 2015;36:752-7. 6908665
95. Tertti K, Laine K, Ekblad U, Rinne V, Ronnemaa T. The degree of fetal metformin exposure does not influence fetal outcome in gestational diabetes mellitus. Acta Diabetologica 2014;51:731-8. 6908666
96. Tertti K, Toppari J, Virtanen HE, Sadov S, Ronnemaa T. Metformin treatment does not affect testicular size in offspring born to mothers with gestational diabetes. Review of Diabetic Studies 2016;13(1):59-65. 6908667
97. Thompson DJ, Porter KB, Gunnells DJ, Wagner PC, Spinnato JA. Prophylactic insulin in the management of gestational diabetes. Obstetrics & Gynecology 1990;75:960-4. 6908669
98. Waheed S, Malik FP, Mazhar SB. Efficacy of metformin versus insulin in the management of pregnancy with diabetes. Journal of the College of Physicians and Surgeons Pakistan 2013;23(12):866-9. 6908671
99. ACTRN12612001272886. A phase three open label randomized controlled trial to compare the efficacy of oral hypoglycaemic agents (OHA) with insulin in the treatment of gestational diabetes mellitus (GDM). anzctr.org.au/Trial/Registration/TrialReview.aspx?id=363218 Date first received: 7 December 2012. 6908673
100. Wali A, Sheikh A, Sheikh L, Babar N, Nausheen S, Akhter J. A phase three open label randomized controlled trial to compare the efficacy of oral hypoglycaemic agents (OHA) with insulin in the treatment of gestational diabetes mellitus (GDM). Diabetes 2015;64:A378. 6908674
101. IRCT201010203797N2. The comparative study if therapeutic effects of insulin and glibenclamide in the gestational diabetes mellitus. en.search.irct.ir/view/4374 Date first received: 1 December 2010. 6908676
102. Zangeneh M, Veisi F, Ebrahimi B, Rezavand N. Comparison of therapeutic effects of insulin and glibenclamide in gestational diabetes. Iranian Journal of Obstetrics, Gynecology and Infertility 2014;17(124):1-7. 6908677
103. Zawiejska A, Wender-Ozegowska E, Grewling-Szmit K, Brazert M, Brazert J. Short-term antidiabetic treatment with insulin or metformin has a similar impact on the components of metabolic syndrome in women with gestational diabetes mellitus requiring antidiabetic agents: Results of a prospective, randomised study. Journal of Physiology and Pharmacology 2016;67(2):227-33. 6908679
104. Ainuddin JA, Karim N, Zaheer S, Ali SS, Hasan AA. Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research 2015;2015:325851. 6908681
105. Ainuddin J, Karim N, Hasan AA, Naqvi SA. Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country: a randomized control trial. Diabetes Research and Clinical Practice 2015;107(2):290-99. 6908683
106. NCT01855763. Metformin treatment in gestational diabetes and non-insulin dependent diabetes in pregnancy in a developing country. clinicaltrials.gov/show/NCT01855763 Date first received: 9 May 2013. 6908684
107. Brennan T, Savitsky L, Frias A, Caughey A. Treating gestational diabetes mellitus with insulin cs glyburide: a cost effectiveness study. American Journal of Obstetrics and Gynecology 2015;212(1):S350. 6908686
108. Coiner J, Rowe M, DeVente J. The treatment of diabetes in pregnancy; metformin vs glyburide and insulin biomedical evidence of fetopathy. American Journal of Obstetrics and Gynecology 2014; Vol. 210, issue 1 Suppl 1:S148. 6908688
109. Fadl HE, Gardefors S, Hjertberg R, Nord E, Persson B, Schwarcz E, et al. Randomized controlled study in pregnancy on treatment of marked hyperglycaemia that is short of overt diabetes. Acta Obstetricia et Gynecologica Scandinavica 2015;94(11):1181-7. 6908690
110. NCT00625781. Treatment of impaired glucose tolerance in pregnancy. clinicaltrials.gov/show/NCT00625781 Date first received: 1 February 2008. 6908691
111. Hassan JA, Karim, Sheikh Z. Metformin prevents macrosomia and neonatal morbidity in gestational diabetes. Pakistan Journal of Medical Sciences 2012;28(3):384-9. 6908693
112. Hopp H, Vollert W, Ragosch V, Novak A, Weitzel HK, Glockner E, et al. Indication and results of insulin therapy for gestational diabetes mellitus. Journal of Perinatal Medicine 1996;24:521-30. 6908695
113. Novak A, Hopp H, Vollert W, Weitzel H, Glockner E. Fetal indication for insulin therapy in gestational diabetes. Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland. Helsinki, Finland, 1994:Abstract no: 318. 6908696
114. Kitzmiller JL. Trial of diet vs diet plus insulin for gestational diabetes. Personal communication 1990. 6908698
115. Landon MB, Rice MM, Varner MW, Casey BM, Reddy UM, Wapner RJ, et al. Mild gestational diabetes mellitus and long-term child health. Diabetes Care 2015;38(3):445-52. 6908700
116. Li DFH, Wong VCW, O'Hoy KMKY, Yeung CY, Ma HK. Is treatment needed for mild impairment of glucose tolerance in pregnancy? A randomized controlled trial. British Journal of Obstetrics and Gynaecology 1987;94:851-4. 6908702
117. Li P, Yang H, Dong Y. Treating women with gestational impaired glucose tolerance reduces adverse outcome of pregnancy. Zhonghua Fu Chan Ke Za Zhi 1999;34(8):462-4. 6908704
118. Gillmer MDG, Maresh M, Beard RW, Elkeles RS, Alderson C, Bloxham B. Low energy diets in the treatment of gestational diabetes. Acta Endocrinologica 1986;277(Supplementum):44-9. 6908706
119. Maresh M, Alderson C, Beard RW, Bloxham B, Elkeles RS, Gillmer MDG. Comparison of insulin against diet treatment in the management of abnormal carbohydrate tolerance in pregnancy. Campbell DM, Gillmer MDG, editor(s). Nutrition in pregnancy. Proceedings of 10th Study Group of the RCOG. London: RCOG, 1983:255-67. 6908707
120. Maresh M, Gillmer MDG, Beard RW, Alderson CS, Bloxham BA, Elkeles RS. The effect of diet and insulin on metabolic profiles of women with gestational diabetes mellitus. Diabetes 1985;34:88-93. 6908708
121. Munshi S, Khandaker S. Evaluation of metformin versus insulin in the management of gestational diabetes mellitus: a prospective comparative study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2014;3(2):357-61. 6908710
122. NCT00678080. Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/show/NCT00678080 Date first received: 8 May 2008. 6908712
123. O'Sullivan JB, Charles D, Dandrow RV. Treatment of verified prediabetics in pregnancy. Journal of Reproductive Medicine 1971;7:21-4. 6908714
124. O'Sullivan JB, Mahan CM, Charles D, Dandrow RV. Medical treatment of the gestational diabetic. Obstetrics and Gynecology 1974;43(6):817-21. 6908715
125. Palatnik A, Mele L, Landon MB, Reddy UM, Ramin SM, Carpenter MW, et al. Timing of treatment initiation for mild gestational diabetes mellitus and perinatal outcomes. American Journal of Obstetrics & Gynecology 2015;213(4):560.e1-8. 6908717
126. Pettitt DJ, Ospina P, Kolaczynski JW, Jovanovic L. Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus. Diabetes Care 2003;26(1):183-6. 6908719
127. Schuster MW, Chauhan SP, McLaughlin BN, Perry KG Jr, Morrison JC. Comparison on insulin regimens and administration modalities in pregnancy complicated by diabetes. Journal of the Mississippi State Medical Association 1998;39(2):51-5. 6908721
128. Smith J, Sallman MA, Berens P, Viteri O, Hutchinson M, Ramin S, et al. Metformin improved lipid profiles in women with gestational diabetes in the first six weeks postpartum. American Journal of Obstetrics and Gynecology 2015;212(1 Suppl):S324. 6908723
129. Snyder J, Morin L, Meltzer S, Nadeau J. Gestational diabetes and glycemic control: A randomized clinical trial. American Journal of Obstetrics and Gynecology. 1998; Vol. 178(1 Pt 2):S55. 6908725
130. Tempe A, Mayanglambam RD. Glyburide as treatment option for gestational diabetes. Journal of Obstetrics and Gynaecology Research 2013;39(6):1147-52. 6908727
131. Afshari F, Abbasalizade F, Faraji M. Comparative evaluation of two treatment regimens, diet versus insulin, in gestational diabetes. European Journal of Experimental Biology 2013;3(4):71-6. 6908729
132. Dunne FP. Randomized trial of twice daily versus four times daily insulin regimens for the treatment of gestational diabetes and gestationally acquired impaired glucose tolerance. National Research Register (www.nrr.nhs.uk) (accessed 2001) 2001. 6908731
133. Ibrahim M, Hamdy A, Shafik A, Taha S, Anwar M, Faris M. The role of adding metformin in insulin-resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics 2014;289:959-65. 6908733
134. Liang HY, Hou F, Ding YL, Zhang WN, Huang XH, Zhang BY, et al. Clinical evaluation of the antioxidant activity of astragalus in women with gestational diabetes. Journal of Southern Medical University 2009;29(7):1402-4. 6908735
135. NCT00160485. Glyburide compared to insulin in the management of White's classification A2 gestational diabetes. clinicaltrials.gov/show/NCT00160485 Date first received: 8 September 2005. 6908737
136. Shaikh N, Safinaz S, Shahnaz R. Can metformin be used in place of insulin for the treatment of GDM in low resource countries?. BJOG: an international journal of obstetrics and gynaecology 2013;120:35. 6908739
137. Todorova K, Palaveev O, Petkova VB, Stefanova M, Dimitrova Z. A pharmacoeconomical model for choice of a treatment for pregnant women with gestational diabetes. Acta Diabetologica 2007;44(3):144-8. 6908741
138. Zhou L, Fan L. Efficacy and safety of insulin aspart versus regular human insulin for women with gestational diabetes mellitus. Zhonghua Yi Xue Za Zhi 2012;92(19):1334-6. 6908743
139. CTRI/2011/08/001956. Can oral medication replace insulin injections in pregnant women with diabetes. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=3378 Date first received: 19 August 2011. 6908745
140. CTRI/2013/10/004055. Use of oral hypoglycemic drug in pregnant diabetic women. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=5526 Date first received: 10 October 2013. 6908747
141. CTRI/2014/08/004835. A clinical trial to compare the effects of metformin versus insulin in patients with diabetes in pregnancy. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=8579 Date first received: 8 July 2014. 6908749
142. IRCT2013102315045N2. Effect of glibenclamide in women with gestational diabetes on maternal and neonatal outcomes. en.search.irct.ir/view/15526 Date first received: 19 April 2014. 6908751
143. IRCT2014010116025N1. Comparing of the effectiveness of insulin and metformin in treating gestational diabetes. en.search.irct.ir/view/16457 Date first received: 18 May 2014. 6908753
144. NCT00414245. Metformin for the treatment of diabetes in pregnancy. clinicaltrials.gov/NCT00414245 Date first received: 20 December 2006. 6908755
145. NCT00681460. Metformin in gestational diabetes mellitus (MetGDM). clinicaltrials.gov/show/NCT00681460 Date first received: 19 May 2008. 6908757
146. NCT00835861. Effectiveness of metformin compared to insulin in pregnant women with mild pre-existing or early gestational diabetes (MIPOD). clinicaltrials.gov/show/NCT00835861 Date first received 2 February 2009. 6908759
147. NCT01613807. Humalog Mix 50/50 (tm) as a treatment for gestational diabetes. clinicaltrials.gov/showNCT01613807 Date first received: 5 June 2012. 6908761
148. NCT01662921. Comparator trial using insulin glulisine vs insulin lispro for treatment of gestational diabetes. clinicaltrials.gov/show/NCT01662921 Date first received: 7 August 2012. 6908763
149. NCT01731431. Multicenter randomized trial of non-inferiority between glyburide and insulin for the treatment of gestational diabetes (INAO). clinicaltrials.gov/show/NCT01731431 Date first received: 11 September 2012. 6908765
150. NCT01756105. Efficacy of metformin in achieving glycaemia goals as recommended for the treatment of gestational diabetes in non obese women. clinicaltrials.gov/show/NCT01756105 Date first received: 19 December 2012. 6908767
151. NCT02080377. A feasibility study looking at the use of glibenclamide and metformin versus standard care in gestational diabetes (GRACES). clinicaltrials.gov/show/NCT02080377 Date first received: 11 February 2014. 6908769
152. NCT03106870. Adding metformin to insulin in controlling pregestational and gestational diabetes mellitus. clinicaltrials.gov/show/NCT03106870 Date first received 28 March 2017. 6908771
153. SLCTR/2011/009. Treatment with metformin to reduce insulin requirements in diabetes in pregnancy. slctr.lk/trials/35 Date first received: 24 June 2011. 6908773
154. American College of Obstetricians and Gynecologists Committee on Practice Bulletins--Obstetrics. ACOG Practice Bulletin No. 137: Gestational diabetes mellitus, August 2013 (replaces practice bulletin number 30, September 2001; Committee Opinion Number 435, June 2009 and Committee Opinion Number 504, September 2011). Obstetrics & Gynecology 2013;122(2 Pt 1):406-16.
155. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013;36(Suppl 1):567-74.
156. Anderberg E, Kallen K, Berntorp K. The impact of gestational diabetes mellitus on pregnancy outcome comparing different cut-off criteria for abnormal glucose tolerance. Acta Obstetricia et Gynecologica Scandinavica 2010;89(12):1532-7.
157. Balsells M, Garcia-Patterson A, Solà I, Roque, Gich I, Corcoy R. Glibenclamide, metformin and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ 2015;350:h102.
158. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 2007;30(Suppl 2):S111-S119.
159. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373(9677):1173-9.
160. Bottalico JN. Recurrent gestational diabetes: risk factors, diagnosis, management, and implications. Seminars in Perinatology 2007;31(3):176-84.
161. Boyadzhieva MV, Atanasova I, Zacharieva S, Tankova T, Dimitrova V. Comparative analysis of current diagnostic criteria for gestational diabetes mellitus. Obstetric Medicine 2012;5:71-7.
162. Brown J, Alwan NA, West J, Brown S, McKinlay CJD, Farrar D, et al. Lifestyle interventions for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews 2017, Issue 5. [DOI: 10.1002/14651858.CD011970.pub2]
163. Brown J, Martis R, Hughes B, Rowan J, Crowther CA. Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews 2017, Issue 1. [DOI: 10.1002/14651858.CD011967.pub2]
164. Catalano PMA, Huston-Presley TL, Amini SB. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. American Journal of Obstetrics & Gynecology 2003;189(6):1698-704.
165. Chamberlain C, McNamara B, Williams E, Yore D, Oldenburg B, Oats J, et al. Diabetes in pregnancy among indigenous women in Australia, Canada, New Zealand and the United States. Diabetes/metabolism Research and Reviews 2013;29(4):241-56.
166. Chasan-Taber L, Schmidt MD, Pekow P, Sternfeld B, Manson JE, Solomon CG, et al. Physical activity and gestational diabetes mellitus among Hispanic women. Journal of Women's Health 2008;17(6):999-1008.
167. Clapp JF. Effects of diet and exercise on insulin resistance during pregnancy. Metabolic Syndrome and Related Disorders 2006;4(2):84-90.
168. Coustan DR, Lowe LP, Metzger BE, Dyer AR, International Association of Diabetes and Pregnancy Study Groups. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus. American Journal of Obstetrics & Gynecology 2010;202(6):654.e1-6.
169. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England Journal of Medicine 2005;352(24):2477-86.
170. Cundy T, Ackermann E, Ryan EA. Gestational diabetes: new criteria may triple the prevalence but effect on outcomes is unclear. BMJ 2014;348:g1567.
171. Cypryk K, Szymczak W, Czupryniak L, Sobczak M, Lewinski A. Gestational diabetes mellitus - an analysis of risk factors. Endokrynologia Polska (Warszawa) 2008;59(5):393-7.
172. Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS, et al. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 2005;28(3):579-84.
173. Devlieger R, Casteels K, Van Assche FA. Reduced adaptation of the pancreatic B cells during pregnancy is the major causal factor for gestational diabetes: current knowledge and metabolic effects on the offspring. Acta Obstetricia et Gynecologica Scandinavica 2008;87(12):1266-70.
174. Duran A, Saenz S, Torrejon M, Bordiu E, del Valle L, Galindo M, et al. Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos Gestational Diabetes Study. Diabetes Care 2014;37:2442-50.
175. Esakoff TF, Cheng YW, Sparks TN, Caughey AB. The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus. American Journal of Obstetrics and Gynecology 2009;200(6):672.e1-672.e4.
176. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007;30(Suppl 2):S141-S146.
177. Girard J. The inhibitory effects of insulin on hepatic glucose production are both direct and indirect. Diabetes 2006;55(Suppl 2):S65-S69.
178. Guerrero-Romero F, Aradillas-García C, Simental-Mendia LE, Monreal-Escalante E, De la Cruz Mendoza E, Rodríguez-Moran M. Birth weight, family history of diabetes, and metabolic syndrome in children and adolescents. Journal of Pediatrics 2010;156(5):719-23.
179. The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. New England Journal of Medicine 2008;358:1991-2002.
180. Harder T, Roepke K, Diller N, Stechling Y, Dudenhausen JW, Plagemann A. Birth weight, early weight gain, and subsequent risk of type 1 diabetes: systematic review and meta-analysis. American Journal of Epidemiology 2009;169(12):1428-36.
181. Hedderson MM, Gunderson EP, Ferrara A. Gestational weight gain and risk of gestational diabetes mellitus. Obstetrics & Gynecology 2010;115(3):597-604.
182. Henriksen T. The macrosomic fetus: a challenge in current obstetrics. Acta Obstetricia et Gynecologica Scandinavica 2008;87(2):134-45.
183. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
184. Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 2007;30(9):2287-92.
185. Hoffman L, Nolan C, Wilson JD, Oats JJ, Simmons D. The Australasian Diabetes in Pregnancy Society. Gestational diabetes mellitus-management guidelines. Medical Journal of Australia 1998;169(2):93-7.
186. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycaemia in pregnancy. Diabetes Care 2010;33(3):676-82.
187. Jastrow N, Roberge S, Gauthier RJ, Laroche L, Duperron L, Brassard N, et al. Effect of birth weight on adverse obstetric outcomes in vaginal birth after cesarean delivery. Obstetrics & Gynecology 2010;115(2 Pt 1):338-43.
188. Jiang Y, Chen X, Wang X, Zhu Z, Su S. Comparative efficacy and safety of oral anti-diabetic drugs in management of gestational diabetes: network meta-analysis of randomized controlled trials. Journal of Clinical Endocrinology and Metabolism 2015;100(5):2071-80.
189. Ju H, Rumbold AR, Willson KJ, Crowther CA. Effect of birth weight on adverse obstetric outcomes in vaginal birth after caesarean delivery. BMC Pregnancy and Childbirth 2008;8:31.
190. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862-8.
191. Kim SY, England L, Wilson HG, Bish C, Satten GA, Dietz P. Percentage of gestational diabetes attributable to overweight and obesity. American Journal of Public Health 2010;100(6):1047-52.
192. Knopp RH, Bergelin RO, Wahl PW, Walden CE. Relationships of infant birth size to maternal lipoproteins, apoproteins, fuels, hormones, clinical chemistries, and body weight at 36 weeks gestation. Diabetes 1985;34(Suppl 2):71-7.
193. Lain KY, Catalano PM. Metabolic changes in pregnancy. Clinical Obstetrics and Gynecology 2007;50(4):938-48.
194. Lambert K, Holt RIG. The use of insulin analogues in pregnancy. Diabetes, Obesity and Metabolism 2013;15:888-900.
195. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. New England Journal of Medicine 2009;361(14):1339-48.
196. Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: the consequences of not treating. American Journal of Obstetrics and Gynecology 2005;192(4):989-97.
197. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998;21(Suppl 2):B161-B167.
198. Metzger B, for The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. New England Journal of Medicine 2008;358:1991-2002.
199. Ministry of Health. Screening, Diagnosis and Management of Gestational Diabetes in New Zealand: A Clinical Practice Guideline. Wellington: Ministry of Health, 2014.
200. Morisset AS, St-Yves A, Veillette J, Weisnagel SJ, Tchernof A, Robitaille J. Prevention of gestational diabetes mellitus: a review of studies on weight management. Diabetes/Metabolism Research and Reviews 2010;26(1):17-25.
201. Morrison JA, Friedman LA, Wang P, Glueck CJ. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years late. Journal of Pediatrics 2008;152(2):201-6.
202. Mulla WR, Henry TQ, Homko CJ. Gestational diabetes screening after HAPO: has anything changed?. Current Diabetes Reports 2010;10(3):224-8.
203. Nankervis A, McIntyre HD, Moses R, Ross GP, Callaway L, Porter C, et al. ADIPS consensus guidelines for the testing and diagnosis of hyperglycaemia in pregnancy in Australia and New Zealand. http://adips.org/downloads/2014ADIPSGDMGuidelinesV18.11.2014.pdf [accessed June 2015] 2014.
204. Negrato CA, Montenegro RM Jr, Von Kostrisch LM, Guedes MF, Mattar R, Gomes MB. Insulin analogues in the treatment of diabetes in pregnancy. Arquivos Brasileiros de Endocrinologia e Metabologia 2012;56(7):405-14.
205. National Institute for Health and Clinical Excellence (NICE). Diabetes in Pregnancy: Management of Diabetes and its Complications from Pre-conception to the Postnatal Period. NICE Clinical Guideline 63. London: NICE, 2008.
206. National Institute for Health and Clinical Excellence (NICE). Diabetes in Pregnancy: Management of Diabetes and its Complications from Pre-conception to the Postnatal Period. NICE Clinical Guideline NG3. London: NICE, 2015.
207. Petry CJ. Gestational diabetes: risk factors and recent advances in its genetics and treatment. British Journal of Nutrition 2010;104(6):775-87.
208. Pettitt DJ, Bennett PH, Knowler WC, Baird HR, Aleck KA. Gestational diabetes mellitus and impaired glucose tolerance during pregnancy. Long-term effects on obesity and glucose tolerance in the offspring. Diabetes 1985;34(Suppl 2):119-22.
209. Pettitt DJ, Nelson RG, Saad MF, Bennett PH, Knowler WC. Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care 1993;16(1):310-4.
210. Reece EA, Leguizamon G, Wiznitzer A. Gestational diabetes: the need for a common ground. Lancet 2009;373(9677):1789-97.
211. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
212. Shah BR, Retnakaran R, Booth GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care 2008;31(8):1668-9.
213. Solomon CG, Willett WC, Carey VJ, Rich-Edwards J, Hunter DJ, Colditz GA, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997;278(13):1078-83.
214. Suman Rao PN, Shashidhar A, Ashok C. In utero fuel homeostasis: Lessons for a clinician. Indian Journal of Endocrinology and Metabolism 2013;17(1):60-8.
215. Tran TS, Hirst JE, Do MA, Morris JM, Jeffrey HE. Early prediction of gestational diabetes mellitus in Vietnam: clinical impact of currently recommended diagnostic criteria. Diabetes Care 2013;36(3):618-24.
216. Vohr BR, Boney CM. Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome?. Journal of Maternal-Fetal Medicine 2008;21(3):149-57.
217. Whincup PH, Kaye SJ, Owen CG, Huxley R, Cook DG, Anazawa S, et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA 2008;300(24):2886-97.
218. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1. Geneva, Switzerland: WHO, 1999.
219. World Health Organization. WHO Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. Report WHO/NMH/MND/13.2. Geneva, Switzerland: WHO, 2014.
220. Zhang C, Liu S, Solomon CG, Hu FB. Dietary fiber intake, dietary glycemic load, and the risk for gestational diabetes mellitus. Diabetes Care 2006;29(10):2223-30.
221. Alwan N, Tuffnell DJ, West J. Treatments for gestational diabetes. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD003395.pub2]
222. Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA. Insulin for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews 2016, Issue 1. [DOI: 10.1002/14651858.CD012037]